348 related articles for article (PubMed ID: 9645985)
1. Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group.
Cerebrovasc Dis; 1998; 8(1):59-72. PubMed ID: 9645985
[TBL] [Abstract][Full Text] [Related]
2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches.
Wahlgren NG; Ahmed N
Cerebrovasc Dis; 2004; 17 Suppl 1():153-66. PubMed ID: 14694293
[TBL] [Abstract][Full Text] [Related]
4. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group.
Diener HC
Cerebrovasc Dis; 1998; 8(3):172-81. PubMed ID: 9619701
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with neuroprotectants and thrombolytics in acute ischaemic stroke.
Steiner T; Hacke W
Eur Neurol; 1998 Jul; 40(1):1-8. PubMed ID: 9693224
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection for ischaemic stroke: current status and challenges.
Moretti A; Ferrari F; Villa RF
Pharmacol Ther; 2015 Feb; 146():23-34. PubMed ID: 25196155
[TBL] [Abstract][Full Text] [Related]
7. Emerging neuroprotective drugs for the treatment of acute ischaemic stroke.
Schmidt A; Minnerup J; Kleinschnitz C
Expert Opin Emerg Drugs; 2013 Jun; 18(2):109-20. PubMed ID: 23600899
[TBL] [Abstract][Full Text] [Related]
8. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection in acute ischaemic stroke. II: Clinical potential.
Davis M; Barer D
Vasc Med; 1999; 4(3):149-63. PubMed ID: 10512595
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection in cerebral infarction: the opportunity of new studies.
Pérez de la Ossa N; Dávalos A
Cerebrovasc Dis; 2007; 24 Suppl 1():153-6. PubMed ID: 17971651
[TBL] [Abstract][Full Text] [Related]
11. Inhalation gases or gaseous mediators as neuroprotectants for cerebral ischaemia.
Sutherland BA; Harrison JC; Nair SM; Sammut IA
Curr Drug Targets; 2013 Jan; 14(1):56-73. PubMed ID: 23170797
[TBL] [Abstract][Full Text] [Related]
12. Prehospital use of magnesium sulfate as neuroprotection in acute stroke.
Saver JL; Starkman S; Eckstein M; Stratton SJ; Pratt FD; Hamilton S; Conwit R; Liebeskind DS; Sung G; Kramer I; Moreau G; Goldweber R; Sanossian N;
N Engl J Med; 2015 Feb; 372(6):528-36. PubMed ID: 25651247
[TBL] [Abstract][Full Text] [Related]
13. Acute care in stroke: the importance of early intervention to achieve better brain protection.
Díez-Tejedor E; Fuentes B
Cerebrovasc Dis; 2004; 17 Suppl 1():130-7. PubMed ID: 14694290
[TBL] [Abstract][Full Text] [Related]
14. Challenges of neuroprotection and neurorestoration in ischemic stroke treatment.
Martínez-Vila E; Irimia P
Cerebrovasc Dis; 2005; 20 Suppl 2():148-58. PubMed ID: 16327266
[TBL] [Abstract][Full Text] [Related]
15. Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: from review to preview.
Grupke S; Hall J; Dobbs M; Bix GJ; Fraser JF
Clin Neurol Neurosurg; 2015 Feb; 129():1-9. PubMed ID: 25497127
[TBL] [Abstract][Full Text] [Related]
16. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
Lestage P; Lockhart B; Roger A
Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
[TBL] [Abstract][Full Text] [Related]
17. Considerations in the design of clinical trials of neuroprotective therapy in acute stroke.
Dorman PJ; Sandercock PA
Stroke; 1996 Sep; 27(9):1507-15. PubMed ID: 8784121
[TBL] [Abstract][Full Text] [Related]
18. [Past, present and future of neuroprotection].
Mracek J
Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
[TBL] [Abstract][Full Text] [Related]
19. ["Brain attack"--care during the acute phase is crucial for the long term outcome].
Wester P
Lakartidningen; 2003 Nov; 100(48):3976-8, 3981-2. PubMed ID: 14717094
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?
De Keyser J; Sulter G; Luiten PG
Trends Neurosci; 1999 Dec; 22(12):535-40. PubMed ID: 10542428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
